Cardinal Health Inc(CAH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 34.48 | EPS (ttm) | 7.24 | Insider Own | 0.24% | Shs Outstand | 233.0M | Perf Week | -1.77% |
| Market Cap | 57.79B | Forward P/E | 17.73 | EPS next Y | 12.23% | Insider Trans | -31.22% | Shs Float | 231.0M | Perf Month | 12.11% |
| Enterprise Value | 63.04B | PEG | 1.55 | EPS next Q | 2.95 | Inst Own | 92.18% | Short Float | 3.19% | Perf Quarter | 8.82% |
| Income | 1.71B | P/S | 0.23 | EPS this Y | 11.38% | Inst Trans | -0.42% | Short Ratio | 4.08 | Perf Half Y | 24.88% |
| Sales | 254.25B | P/B | - | EPS next 5Y | 11.46% | ROA | 3.1% | Short Interest | 7.37M | Perf YTD | 21.45% |
| Book/sh | -12.37 | P/C | 11.9 | EPS past 3/5Y | 79.07% 28.33% | ROE | - | 52W High | -3.72% ($259.21) | Perf Year | 56.8% |
| Cash/sh | 20.97 | P/FCF | 12.77 | Sales past 3/5Y | 7.44% 9.37% | ROIC | 34.4% | 52W Low | 57.26% ($158.70) | Perf 3Y | 171.3% |
| Dividend Est. | $2.08 (0.83%) | EV/EBITDA | 14.88 | EPS Y/Y TTM | 12.28% | Gross Margin | 3.7% | Volatility(W/M) | 2.01% 2.32% | Perf 5Y | 403.47% |
| Dividend TTM | 2.05 | EV/Sales | 0.25 | Sales Y/Y TTM | 14.23% | Oper. Margin | 1.29% | ATR (14) | 5.56 | Perf 10Y | 232.1% |
| Dividend Ex-Date | 2026/10/1 | Quick Ratio | 0.49 | EPS Q/Q | 70.07% | Profit Margin | 0.67% | RSI (14) | 60.38 | Recom | 1.57 |
| Dividend Gr. 3/5Y | 1% 1.01% | Current Ratio | 0.88 | Sales Q/Q | 5.84% | SMA20 | 3.85% ($240.32) | Beta | 0.54 | Target Price | $276 |
| Payout | 28.32% | Debt/Eq | - | Earnings | 2026/11/5 | SMA50 | 5.63% ($236.27) | Rel Volume | 0.92 | Prev Close | $255.64 |
| Employees | 63900 | LT Debt/Eq | - | EPS/Sales Surpr. | 20.26% -2.27% | SMA200 | 12.89% ($221.07) | Avg Volume(3M) | 1.81M | Price | $249.57 |
| IPO | 1983/8/4 | Option/Short | Yes/Yes | Trades | 18757 | Volume | 1,665,850 | Change | -2.37% |
💊 A global leader in pharmaceutical distribution, providing wholesale distribution of pharmaceuticals and medical devices as well as specialty healthcare solutions in the United States. Founded in 1971 and headquartered in the U.S., it is part of one of the three major pharmaceutical wholesale distribution groups in the country.
Over the past 1 year, on the higher side
4% below its 1-year high.
Traded about as much as usual. That is 92% of its average volume.
Next earnings report: November 5
10 days to go.
CAH has weak earnings and a weak balance sheet
Of every $100 in sales, $1.29 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +11.4% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $1,773. Peers typically go for $1,761. Compared with its own 4-year average, it is 15% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +403.5%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.83% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 92.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #3 of 10 in the industry
Based on market cap of $58B.
MCK#1 Mckesson Corp $117B PER 26.8 
COR#2 Cencora Inc $63B PER 24.6 
CAH#3 Cardinal Health Inc $58B PER 34.5 
HSIC#4 Henry Schein Inc $9B PER 24.8 
AHG#5 Akso Health Group ADR $1B PER - 
FAQ
What kind of company is CAH?
CAH belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is the market cap of CAH?
The market cap of CAH is approximately $57.8B, ranking 287 within its sector.
Does CAH pay dividends?
CAH has a dividend yield of approximately 0.83%, with an annual dividend of $2.08.
What is the P/E ratio of CAH?
CAH has a P/E ratio of approximately 34.5x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for CAH?
CAH has recorded a 52-week high of $259.21 and a low of $158.70.
